Unjha Formulations P/E Ratio
Current P/E Ratio
12.1
Low Valuation
Low - May indicate good value opportunity
Unjha Formulations (UNJHAFOR) P/E ratio is 12.1 (Low), EPS (TTM) ₹1.57, current price ₹18.55 on BSE — Low - May indicate good value opportunity. For live price, revenue and the complete fundamental profile, see Unjha Formulations stock price NSE.
Current Valuation Metrics
P/E Ratio
12.1
Current Price
₹18.55
EPS (TTM)
₹1.57
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
55.02
Sector Median
31.4
Sector Rank
#11 of 194
Sector Percentile
5.7%
UNJHAFOR P/E Ratio — Valuation Signal & Historical Context
Unjha Formulations P/E 12.1 — signal: Fairly Valued. See UNJHAFOR book value comparison to compare market price against book value per share.
- Stock appears undervalued with PE of 12.1, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.02
UNJHAFOR vs Healthcare Peers — P/E Ratio Comparison
Unjha Formulations P/E 12.1 vs Healthcare average 55.02, median 31.4 — range 2.86–950.0.
Sector Average
55.02
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
950.0
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.89 | ₹69 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |